Emilien DUGRAND

Emilien DUGRAND

Scientific Analyst

Emilien is responsible for the evaluation of new technologies and products.

Prior to Ginward, Emilien accumulated professional experiences in the health sector. Among his key experiences, Emilien worked at Servier Laboratories as a business developer in the Oncology Business Unit of the French subsidiary and in the Sales and Operations Department. He was a Self-Entrepreneur for one year in Paris, where he carried out operational consulting missions for both e-health start-ups and consumer healthcare laboratories. Emilien has an in-depth knowledge of city pharmacies and the hospital sector.

Emilien holds a PhD in Pharmacy from the University of Montpellier in France, with a specialization in Industrial Pharmacy. His Thesis in 2018 focused on access to the CAR-T cell therapy market in France.  In September 2019, he joined a Master of Science in Strategy and Management in International Business from ESSEC Business School in Singapore.

Emilien is native in French, fluent in English, and intermediate in Spanish

Edward Willems

Edward WILLEMS

Managing Director & Co-founder

Ginger Hsiao

Ginger HSIAO

Co-founder

Shang Hsiao

Shang HSIAO

Co-founder and Venture Partner

Fumiaki YUMOTO, PhD

Country Head Japan, Managing Director

Jaap Weiling

Jaap WIELING

Venture Partner and Scientific Advisor

William ONG, PhD

Technical Analyst

Ha Linh NGUYEN

Technical Analyst

Jack CHAN

Financial Analyst

Sun YI

Financial Analyst

Dr. Bert Tjeenk Willink

Advisor and Venture Partner

Andrew Lin

Andrew LIN

Advisor

Clark Su

Clark SU

Advisor

Adam Kirby

Adam KIRBY

Advisor

Jerry Hong

Jerry HONG

Advisor